| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
|
6,252 |
5,940 |
$703K |
| 99284 |
|
5,185 |
4,962 |
$476K |
| 99283 |
|
5,119 |
4,912 |
$342K |
| T1015 |
Clinic visit/encounter, all-inclusive |
3,138 |
1,960 |
$130K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,302 |
1,247 |
$109K |
| 87426 |
|
2,235 |
2,128 |
$70K |
| G0378 |
Hospital observation service, per hour |
308 |
181 |
$61K |
| 80048 |
|
7,977 |
7,103 |
$55K |
| 85025 |
|
10,401 |
9,085 |
$48K |
| 80050 |
|
939 |
931 |
$44K |
| 74177 |
|
260 |
254 |
$43K |
| 87804 |
|
1,793 |
1,760 |
$40K |
| 96374 |
|
1,464 |
1,348 |
$32K |
| 84450 |
|
5,944 |
5,603 |
$31K |
| 83615 |
|
5,751 |
5,402 |
$31K |
| 82306 |
|
894 |
887 |
$31K |
| 93976 |
|
453 |
439 |
$30K |
| 82247 |
|
5,730 |
5,371 |
$29K |
| 83735 |
|
4,823 |
4,378 |
$26K |
| 82150 |
|
5,737 |
5,396 |
$22K |
| 84075 |
|
4,789 |
4,508 |
$22K |
| 80061 |
|
1,571 |
1,553 |
$21K |
| 77067 |
|
258 |
256 |
$20K |
| 80053 |
|
1,596 |
1,389 |
$16K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
41 |
41 |
$16K |
| 93005 |
|
2,057 |
1,859 |
$15K |
| 84443 |
|
785 |
762 |
$15K |
| 83690 |
|
3,405 |
3,193 |
$13K |
| 70450 |
|
226 |
220 |
$12K |
| 84484 |
|
1,842 |
1,531 |
$12K |
| 93306 |
|
196 |
189 |
$12K |
| 87086 |
|
1,733 |
1,606 |
$11K |
| 70553 |
|
58 |
58 |
$11K |
| 84460 |
|
1,906 |
1,833 |
$11K |
| 71045 |
|
1,522 |
1,407 |
$11K |
| 87491 |
|
465 |
454 |
$11K |
| 42820 |
|
13 |
13 |
$11K |
| 87591 |
|
465 |
454 |
$11K |
| 85730 |
|
1,688 |
1,582 |
$9K |
| 87635 |
|
238 |
232 |
$9K |
| 87476 |
|
242 |
232 |
$9K |
| 82607 |
|
735 |
727 |
$9K |
| 82550 |
|
1,763 |
1,585 |
$9K |
| 96375 |
|
548 |
421 |
$8K |
| 87040 |
|
441 |
409 |
$8K |
| 88175 |
|
239 |
234 |
$7K |
| 83036 |
|
944 |
933 |
$6K |
| 84439 |
|
827 |
819 |
$6K |
| 74176 |
|
94 |
93 |
$6K |
| 85610 |
|
2,098 |
1,889 |
$6K |
| 77063 |
|
246 |
244 |
$5K |
| 82746 |
|
441 |
441 |
$5K |
| 81001 |
|
2,043 |
1,911 |
$5K |
| 71046 |
|
382 |
373 |
$5K |
| 76536 |
|
92 |
91 |
$4K |
| 86780 |
|
272 |
271 |
$4K |
| 84145 |
|
198 |
188 |
$4K |
| 83605 |
|
626 |
557 |
$4K |
| 76805 |
|
75 |
70 |
$4K |
| 80307 |
|
81 |
77 |
$3K |
| 82728 |
|
276 |
271 |
$3K |
| 96372 |
|
322 |
257 |
$3K |
| 87389 |
|
99 |
98 |
$3K |
| 83540 |
|
320 |
313 |
$3K |
| 82043 |
|
308 |
306 |
$2K |
| 84702 |
|
152 |
104 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
49 |
49 |
$2K |
| 73630 |
|
243 |
228 |
$2K |
| 81003 |
|
843 |
782 |
$2K |
| 97161 |
|
66 |
61 |
$2K |
| 83880 |
|
84 |
76 |
$2K |
| 76856 |
|
52 |
52 |
$2K |
| 80076 |
|
247 |
233 |
$2K |
| 72148 |
|
12 |
12 |
$2K |
| 73610 |
|
122 |
120 |
$2K |
| 81025 |
|
550 |
522 |
$2K |
| 85378 |
|
220 |
211 |
$2K |
| 87430 |
|
290 |
281 |
$2K |
| 87070 |
|
308 |
295 |
$2K |
| 86140 |
|
688 |
640 |
$2K |
| 84436 |
|
197 |
194 |
$2K |
| 87186 |
|
218 |
204 |
$2K |
| 76817 |
|
32 |
26 |
$2K |
| 93010 |
|
833 |
622 |
$2K |
| 86850 |
|
213 |
198 |
$2K |
| 76830 |
|
41 |
40 |
$2K |
| 88305 |
|
226 |
214 |
$2K |
| 87807 |
|
113 |
109 |
$1K |
| 87340 |
|
96 |
96 |
$1K |
| 80305 |
|
160 |
151 |
$1K |
| 86038 |
|
88 |
86 |
$1K |
| 84479 |
|
153 |
152 |
$1K |
| 85651 |
|
430 |
409 |
$1K |
| 72110 |
|
73 |
72 |
$1K |
| 83550 |
|
241 |
235 |
$1K |
| 73130 |
|
82 |
75 |
$932.36 |
| 76705 |
|
28 |
28 |
$902.63 |
| 86901 |
|
214 |
199 |
$784.74 |
| 86900 |
|
214 |
199 |
$779.20 |
| 82565 |
|
151 |
145 |
$767.79 |
| 86803 |
|
38 |
38 |
$731.01 |
| 73030 |
|
65 |
59 |
$722.38 |
| 87088 |
|
117 |
111 |
$717.79 |
| 96365 |
|
32 |
27 |
$690.50 |
| 82553 |
|
77 |
68 |
$646.74 |
| 87081 |
|
104 |
104 |
$621.36 |
| 82248 |
|
86 |
86 |
$603.42 |
| 94729 |
|
28 |
28 |
$580.90 |
| 87077 |
|
94 |
89 |
$490.08 |
| 84550 |
|
83 |
78 |
$467.41 |
| 84153 |
|
17 |
17 |
$425.63 |
| 86617 |
|
14 |
14 |
$400.90 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,263 |
1,102 |
$385.87 |
| 84403 |
|
14 |
13 |
$385.29 |
| 82951 |
|
27 |
26 |
$369.26 |
| 86762 |
|
17 |
17 |
$365.21 |
| 94727 |
|
26 |
26 |
$360.65 |
| 74019 |
|
24 |
24 |
$341.82 |
| 94060 |
|
42 |
42 |
$324.36 |
| 86787 |
|
15 |
15 |
$270.17 |
| 82784 |
|
14 |
12 |
$238.82 |
| 94664 |
|
27 |
26 |
$227.63 |
| 85027 |
|
32 |
27 |
$214.27 |
| 36415 |
|
1,796 |
1,467 |
$212.56 |
| 83001 |
|
12 |
12 |
$211.75 |
| 84100 |
|
32 |
29 |
$194.24 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
767 |
753 |
$193.40 |
| 74018 |
|
14 |
14 |
$181.38 |
| 84165 |
|
12 |
12 |
$163.36 |
| 73560 |
|
16 |
14 |
$161.88 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
45 |
36 |
$145.47 |
| 85007 |
|
33 |
27 |
$128.25 |
| 73502 |
|
12 |
12 |
$108.27 |
| 86376 |
|
14 |
13 |
$102.34 |
| J3490 |
Unclassified drugs |
223 |
192 |
$99.50 |
| 84703 |
|
12 |
12 |
$90.01 |
| 86431 |
|
13 |
12 |
$84.77 |
| 87880 |
|
14 |
14 |
$83.16 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,756 |
1,462 |
$68.36 |
| 84520 |
|
14 |
13 |
$62.94 |
| 87205 |
|
13 |
12 |
$33.53 |
| J2704 |
Injection, propofol, 10 mg |
1,194 |
1,136 |
$28.80 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
935 |
833 |
$8.19 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
583 |
508 |
$6.48 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,312 |
1,028 |
$5.93 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
987 |
857 |
$1.48 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
901 |
833 |
$0.60 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
31 |
28 |
$0.00 |
| 3052F |
|
13 |
13 |
$0.00 |
| 88304 |
|
39 |
39 |
$0.00 |
| 3044F |
|
161 |
158 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
13 |
13 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
13 |
12 |
$0.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
117 |
116 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
33 |
25 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
17 |
12 |
$0.00 |
| 3051F |
|
27 |
27 |
$0.00 |